Exacerbation of COVID 19 in Hypertensive Patients （ A review ）

Abstract

Since its discovery in December 2019, corona virus was outbreak worldwide with a very rapid rate, so it described by World Health Organization (WHO) as a pandemic. It associated with severe acute respiratory distress syndrome, and can invade the cells through Angiotensin Converting Enzyme 2 (ACE 2) receptor which play an important role as regulator for blood pressure. Hypertension is a potential risk factor for sever acute respiratory syndrome COVID-19, and associated with high mortality rate as shown in many epidemiological studies. A lot of published article reviews, retrospective and meta-analysis regard the association between COVID-19 and hypertension. Moreover, specific antihypertensive medications that infected patients were receiving are not known; only data about renin-angiotensin-aldosterone system (RAAS) are available. Objective: To summarize the most updated data of COVID-19 in hypertensive patients.